Mr Mrs Miss Ms Dr Other

Dr
Jade
Cheng

Patent Attorney

London Office

Life sciences

Telephone. +44 (0)207 776 5100
Email. [email protected]

Experience

Jade joined the Life Sciences group of HGF in February 2022 as a qualified UK and European Patent Attorney.

Prior to being a Patent Attorney, Jade was a postdoctoral fellow at the Medical Research Council Laboratory of Molecular Biology (MRC LMB) in Cambridge. During her time as an academic, she investigated diverse subjects including the blood brain barrier, mechanisms of cell death and embryonic development.

Jade’s experience in academia means she understands the patenting process from academics' point of view and is ideally placed to work alongside universities’ technology transfer departments and their academics.

Jade’s main areas of focus in patent practice are on antibodies, vaccines, medical treatments and sequencing technologies. She has experience with drafting and filing applications, prosecution, freedom-to-operate analyses, third party observations, EPO oppositions and appeals, and providing filing strategies. She also advises clients on prosecution in many foreign jurisdictions.

Jade enjoys being a member of the HGF Venture team with Kerry Rees to provide IP due diligence services to life science investors. As a consequence, Jade also works with early stage companies to help them align their IP strategies with their business plan to maximum the return on investment.

Jade is fluent in English and Cantonese.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

Biochemistry

PHD

Biochemistry

Conferences: 2023

November 21st 2023

LSPN Europe 2023

Attended

Event details

Related News

New Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article
Event - 16th November 2023

Webinar in cooperation with the BVIZ: Licensing and Technology Transfer

HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …

Event details

Investing in Patents for Space Tech: Safeguarding Innovations in the Space Sector

The advent of commercial launch capabilities has opened up space as a unique frontier for innovation. However, in space, any acts of patent infringement almost always go unseen. Thus, it’s …

Read article

End of EPO "10 day rule" from 1 November 2023 – 4 weeks to go

Any communications sent from the EPO on or after 1 November 2023 will no longer have the “ten day rule” applied to them.   This means that communications are deemed to …

Read article
Event - 21st, 28th November 2023

Dresden & Salzburg Seminar: Licensing and Technology Transfer

HGF is pleased to invite you to our upcoming German-language seminar on “In- and Out-licensing of Technologies” in Salzburg and Dresden. The seminar will offer you the opportunity to gain …

Event details
Event - 26th September 2023

Bioforward OBN Conference 2023

Bioforward, OBN’s ‘Roadmap for Growth’ Life Sciences event is set to take place at The King’s Centre in Oxford on Tuesday 26th September 2023. This event is designed to provide the support, skills, know-how …

Event details

AI-Powered Personalised Medicine

The integration of artificial intelligence (AI) into healthcare has ushered in a new era of personalised medicine, promising more effective and tailored treatments for patients. Traditional medical approaches often adopt …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.